Stock NXTMH NEXSTIM PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nexstim Plc

Equities

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki
Other stock markets
 08:59:32 10/05/2024 pm IST 		5-day change 1st Jan Change
2.83 EUR +4.04% Intraday chart for Nexstim Plc +7.60% -3.74%
08/05 Nexstim Plc Receives an Order for an NBS System 5 from a Hospital in Finland CI
06/05 Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7.22 43 31.96 27.6 19.89 19.15 - -
Enterprise Value (EV) 1 9.231 44.58 30.66 26.65 19.89 20.95 20.55 19.15
P/E ratio -0.46 x -4.89 x -34.1 x 22.8 x -14.7 x -25.7 x 40.4 x 17.7 x
Yield - - - - - - - 1.77%
Capitalization / Revenue 2.16 x 10.5 x 5 x 2.9 x 2.74 x 2.31 x 1.77 x 1.46 x
EV / Revenue 2.76 x 10.8 x 4.79 x 2.8 x 2.74 x 2.52 x 1.9 x 1.46 x
EV / EBITDA -1.54 x -15 x -30.4 x 19.9 x - 209 x 17.1 x 9.57 x
EV / FCF - -16.4 x -8.25 x -60.8 x - 17.5 x 41.1 x 13.7 x
FCF Yield - -6.11% -12.1% -1.64% - 5.73% 2.43% 7.31%
Price to Book - - - 6.78 x - 10.1 x 8.32 x -
Nbr of stocks (in thousands) 628 4,396 6,687 6,715 6,766 6,766 - -
Reference price 2 11.50 9.780 4.780 4.110 2.940 2.830 2.830 2.830
Announcement Date 28/02/20 26/02/21 28/02/22 27/02/23 27/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3.348 4.114 6.398 9.527 7.246 8.3 10.8 13.1
EBITDA 1 -5.993 -2.966 -1.009 1.338 - 0.1 1.2 2
EBIT 1 -6.517 -3.333 -1.452 0.8403 -1.228 -0.7 0.6 1.4
Operating Margin -194.66% -81.01% -22.7% 8.82% -16.95% -8.43% 5.56% 10.69%
Earnings before Tax (EBT) 1 -6.777 -4.117 -0.7333 1.311 - -0.8 0.5 1.1
Net income 1 -6.783 -4.122 -0.8321 1.307 - -0.8 0.5 1.1
Net margin -202.58% -100.18% -13.01% 13.72% - -9.64% 4.63% 8.4%
EPS 2 -25.00 -2.000 -0.1400 0.1800 -0.2000 -0.1100 0.0700 0.1600
Free Cash Flow 1 - -2.725 -3.718 -0.4381 - 1.2 0.5 1.4
FCF margin - -66.23% -58.11% -4.6% - 14.46% 4.63% 10.69%
FCF Conversion (EBITDA) - - - - - 1,200% 41.67% 70%
FCF Conversion (Net income) - - - - - - 100% 127.27%
Dividend per Share 2 - - - - - - - 0.0500
Announcement Date 28/02/20 26/02/21 28/02/22 27/02/23 27/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 6.793 2.734 2.504 4.743 3.4 4.9 4.2 6.6
EBITDA 1 2.553 -1.215 -1.078 - -0.5 0.6 -0.6 1.2
EBIT 1 2.333 -1.493 -1.387 0.1593 -0.9 0.2 -0.6 1.2
Operating Margin 34.35% -54.62% -55.41% 3.36% -26.47% 4.08% -14.29% 18.18%
Earnings before Tax (EBT) 1 3.214 -1.902 -1.439 - -1 0.2 -0.6 1.2
Net income 1 3.209 -1.903 -1.442 - -1 0.2 -0.6 1.2
Net margin 47.25% -69.6% -57.61% - -29.41% 4.08% -14.29% 18.18%
EPS 2 0.4400 -0.2800 -0.2100 - -0.1400 0.0200 -0.0900 0.1700
Dividend per Share - - - - - - - -
Announcement Date 12/08/22 27/02/23 18/08/23 27/02/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2.01 1.59 - - - 1.8 1.4 -
Net Cash position 1 - - 1.3 0.95 - - - -
Leverage (Debt/EBITDA) -0.3355 x -0.5356 x - - - 18 x 1.167 x -
Free Cash Flow 1 - -2.72 -3.72 -0.44 - 1.2 0.5 1.4
ROE (net income / shareholders' equity) - - - 35.9% - -33.5% 21.6% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - - 0.6100 - 0.2800 0.3400 -
Cash Flow per Share 2 - - - 0.1400 - 0.2400 0.1600 -
Capex 1 0.84 - 1.61 1.44 - 0.6 0.7 0.7
Capex / Sales 25.19% - 25.14% 15.12% - 7.23% 6.48% 5.34%
Announcement Date 28/02/20 26/02/21 28/02/22 27/02/23 27/02/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.83 EUR
Average target price
3 EUR
Spread / Average Target
+6.01%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
NEXSTIM PLC Stock Nexstim Plc
-3.74% 20.62M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.73% 226B
DANAHER CORPORATION Stock Danaher Corporation
+9.53% 188B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+14.63% 137B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+27.47% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.04% 63.19B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.73% 52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.86% 51B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.72% 43.89B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+7.86% 38.07B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. NXTMH Stock
  4. Financials Nexstim Plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW